Methinks Stroke Suite is a disruptive technology that has the potential to provide early,
automated detection of large vessel occlusions, both hyperdense and not, from non-contrast
BARCELONA, February 21, 2023 – Methinks, a digital health Company that specializes in
early detection and management of Acute Stroke (AS), using artificial intelligence (AI), today
announced that it has received CE mark for its medical imaging software, Methinks Stroke
Suite following a milestone year of development progress, enabling commercialization in
Europe and to assist in emergency settings for the benefit of AS patients.